Castile Resources【CST】銘柄情報

Castile Resources Limited (CST) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.079

( -4.82% )

買値

0.08

売値

0.083

出来高

5,000

0.079 日の範囲 0.079

0.053 52 週間の範囲 0.15

時価総額

24.154M

前日終値

0.083

始値

0.079

時刻

5000

0.079

最終取引時間

09:52:52

財務取引量

VWAP

平均取引量 (3 か月)

AUD 486,791

発行済株式数

305,748,580

配当利回り

PER

-25.37

1 株当たり利益 (EPS)

-0

歳入

239.96k

純利益

-911.78k

Castile Resources Limited engages in the mineral exploration and project development activities in Australia. It focuses on exploring for copper, gold, lead, cobalt, silver, zinc, bismuth, and other base metals. The company’s flagship project owned 100% interests in the Rover projects located in the... Castile Resources Limited engages in the mineral exploration and project development activities in Australia. It focuses on exploring for copper, gold, lead, cobalt, silver, zinc, bismuth, and other base metals. The company’s flagship project owned 100% interests in the Rover projects located in the Northern Territory. Castile Resources Limited was incorporated in 2007 and is based in West Leederville, Australia. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

www.castile.com.au

本社

West Leederville, Australia

設立

2026

Castile Resources Limited is listed in the Materials sector of the オーストラリア証券取引所 with ticker CST. The last closing price for Castile Resources was AUD0.08. Over the last year, Castile Resources shares have traded in a share price range of AUD 0.053 to AUD 0.15.

Castile Resources currently has 305,748,580 shares in issue. The market capitalisation of Castile Resources is AUD24.15 million. Castile Resources has a price to earnings ratio (PE ratio) of -25.37.

QIAGEN Makes Proposal to Acquire Australian Diagnostics Company Cellestis Limited

QIAGEN Makes Proposal to Acquire Australian Diagnostics Company Cellestis Limited PR Newswire VENLO, Netherlands and MELBOURNE, Australia, April...

QIAGEN Makes Proposal to Acquire Australian Diagnostics Company Cellestis Limited

QIAGEN Makes Proposal to Acquire Australian Diagnostics Company Cellestis Limited -- QIAGEN to acquire Cellestis Limited (CST:AU) via a Scheme of...

CO2 Solution Inc. Presents at First Federal Conservative BioCaucus Meeting

Trading symbol: CST Outstanding shares: 50,261,136 OTTAWA, June 4 /PRNewswire-FirstCall/ -- CO2 Solution Inc. is pleased to announce that its...

Cellestis Limited (ASX:CST) Announce a New Australian Blood Test Proven Six Times More Effective For Tuberculosis Control

Melbourne, Australia, Feb 15, 2008 - (ABN Newswire) - In a landmark study electronically published today in the American Journal of Respiratory...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.012	17.9104477612	0.067	0.083	0.067	188604	0.07877181	DE
4	-0.01	-11.2359550562	0.089	0.095	0.067	924578	0.08900483	DE
12	-0.014	-15.0537634409	0.093	0.105	0.067	519341	0.09073053	DE
26	-0.041	-34.1666666667	0.12	0.15	0.067	484403	0.10784527	DE
52	0.024	43.6363636364	0.055	0.15	0.053	574153	0.1003287	DE
156	-0.003	-3.65853658537	0.082	0.15	0.047	293201	0.09081897	DE
260	-0.161	-67.0833333333	0.24	0.27	0.047	249924	0.11738756	DE